{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["6-methoxykynurenic acid", "ADME", "Ephedra foeminea", "alkaloids", "in silico", "proanthocyanidins", "tumor marker"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38202783", "DateCompleted": {"Year": "2024", "Month": "01", "Day": "12"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "12"}, "Article": {"Language": ["eng"], "ELocationID": ["199", "10.3390/molecules29010199"], "ArticleDate": [{"Year": "2023", "Month": "12", "Day": "29"}], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "29", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "29"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Bio-Guided Assay of <i>Ephedra foeminea</i> Forssk Extracts and Anticancer Activities: In Vivo, In Vitro, and In Silico Evaluations.", "Abstract": {"AbstractText": ["<i>Ephedra</i> is one of the oldest known medicinal plants and the largest genera of the Ephedraceae family. In vivo antitumor evaluation of <i>Ephedra foeminea</i> revealed that ethyl acetate (EtOAc) was the most bioactive fraction. Bio-guided fractionation of EtOAc fraction afforded nine compounds isolated for the first time from the plant species. Macrocyclic spermine alkaloids (1,9), proanthocyanidins (2,4,5), quinoline alkaloids (7,8), phenolic (3), and nucleoside (6) were identified and elucidated by spectroscopic analyses including 1D and 2D NMR, ESI-MS-MS spectrometry. The tested compounds exhibited moderate anticancer activity, except for the kynurenic acid derivative (6-mKYNA) which showed significant cytotoxicity and remarkable inhibition of CA-19.9 and CA-125 tumor biomarkers. In-silico study was conducted to determine the anti-proliferative mechanism of 6-mKYNA by using the CK2 enzyme active site. Moreover, the ADME computational study suggested that 6-mKYNA is an effective candidate with a promising pharmacokinetic profile and therapeutic potential against various types of cancer."]}, "AuthorList": [{"Identifier": ["0000-0003-1149-8222"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, Faculty of Pharmacy, October 6 University, 6th of October City 12585, Egypt."}], "LastName": "Nazeam", "ForeName": "Jilan A", "Initials": "JA"}, {"Identifier": ["0000-0003-4059-2912"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Department, Faculty of Pharmacy, October 6 University, 6th of October City 12585, Egypt."}], "LastName": "Boshra", "ForeName": "Sylvia A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Chemistry Department, Faculty of Pharmacy, October 6 University, 6th of October City 12585, Egypt."}], "LastName": "Mohammed", "ForeName": "Esraa Z", "Initials": "EZ"}, {"Identifier": ["0000-0002-1543-8844"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, Faculty of Pharmacy, October 6 University, 6th of October City 12585, Egypt."}], "LastName": "El Gizawy", "ForeName": "Heba A", "Initials": "HA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "76845O8NMZ", "NameOfSubstance": "ethyl acetate"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Acetates"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Ephedra"}, {"QualifierName": [], "DescriptorName": "Biological Assay"}, {"QualifierName": [], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Acetates"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hollander L., Vander B., Baguley G. Evolution of seed dispersal in North American Ephedra. Evol. Ecol. 2010;24:333\u2013345. doi: 10.1007/s10682-009-9309-1.", "ArticleIdList": ["10.1007/s10682-009-9309-1"]}, {"Citation": "Amakura Y., Yoshimura M., Yamakami S., Yoshida T., Wakana D., Hyuga M., Hyuga S., Hanawa T., Goda Y. Characterization of phenolic constituents from ephedra herb extract. Molecules. 2013;18:5326\u20135334. doi: 10.3390/molecules18055326.", "ArticleIdList": ["10.3390/molecules18055326", "PMC6271103", "23666001"]}, {"Citation": "Gonz\u00e1lez-Ju\u00e1rez D.E., Escobedo-Moratilla A., Flores J., Hidalgo-Figueroa S., Mart\u00ednez-Tag\u00fce\u00f1a N., P\u00e9rez-Miranda S., Ram\u00edrez-Hern\u00e1ndez A., Trujillo J. A review of the Ephedra genus: Distribution, ecology, ethnobotany, phytochemistry and pharmacological properties. Molecules. 2020;25:3283. doi: 10.3390/molecules25143283.", "ArticleIdList": ["10.3390/molecules25143283", "PMC7397145", "32698308"]}, {"Citation": "Li L., Chen J. Research progress on Ephedra and its active ingredients. J. Xinjiang Med. Univ. 2003;26:606\u2013608."}, {"Citation": "Krizevski R., Bar E., Shalit O., Sitrit Y., Ben-Shabat S., Lewinsohn E. Composition and stereochemistry of ephedrine alkaloids accumulation in Ephedra sinica Stapf. Phytochemistry. 2010;71:895\u2013903. doi: 10.1016/j.phytochem.2010.03.019.", "ArticleIdList": ["10.1016/j.phytochem.2010.03.019", "20417943"]}, {"Citation": "Song K.S., Ishikawa Y., Kobayashi S., Sankawa U., Ebizuka Y. N-Acylamino acids from Ephedra distachya cultures. Phytochemistry. 1992;31:823\u2013826. doi: 10.1016/0031-9422(92)80021-6.", "ArticleIdList": ["10.1016/0031-9422(92)80021-6"]}, {"Citation": "Starratt A.N., Caveney S. Four cyclopropane amino acids from Ephedra. Phytochemistry. 1995;40:479\u2013481. doi: 10.1016/0031-9422(95)00342-5.", "ArticleIdList": ["10.1016/0031-9422(95)00342-5"]}, {"Citation": "Castledine R.M., Harborne J.B. Identification of the glycosyl flavones of Ephedra and Briza by mass spectrometry of their permethyl ethers. Phytochemistry. 1976;15:803\u2013804. doi: 10.1016/S0031-9422(00)94450-9.", "ArticleIdList": ["10.1016/S0031-9422(00)94450-9"]}, {"Citation": "Nawwar M.A., El-Sissi H.I., Barakat H.H. Flavonoid constituents of Ephedra alata. Phytochemistry. 1984;23:2937\u20132939. doi: 10.1016/0031-9422(84)83045-9.", "ArticleIdList": ["10.1016/0031-9422(84)83045-9"]}, {"Citation": "Hussein S.A., Barakat H.H., Nawar M.A., Willuhn G. Flavonoids from Ephedra aphylla. Phytochemistry. 1997;45:1529\u20131532. doi: 10.1016/S0031-9422(97)00092-7.", "ArticleIdList": ["10.1016/S0031-9422(97)00092-7"]}, {"Citation": "Mighri H., Akrout A., Bennour N., Eljeni H., Zammouri T., Neffati M. LC/MS method development for the determination of the phenolic compounds of Tunisian Ephedra alata hydro-methanolic extract and its fractions and evaluation of their antioxidant activities. S. Afr. J. Bot. 2019;124:102\u2013110. doi: 10.1016/j.sajb.2019.04.029.", "ArticleIdList": ["10.1016/j.sajb.2019.04.029"]}, {"Citation": "Bansal V., Kumar P., Tuteja S.K., Siddiqui M.W. Plant Secondary Metabolites. Volume Three (235\u2013258) Apple Academic Press; Oxford, UK: 2017. Diverse utilization of plant-originated secondary metabolites."}, {"Citation": "Zhang B.M., Wang Z.B., Xin P. Phytochemistry and pharmacology of genus Ephedra. Chin. J. Nat. Med. 2018;16:811\u2013828. doi: 10.1016/S1875-5364(18)30123-7.", "ArticleIdList": ["10.1016/S1875-5364(18)30123-7", "30502763"]}, {"Citation": "Elhadef K., Smaoui S., Fourati M., Ben Hlima H., Chakchouk Mtibaa A., Sellem I., Ennouri K., Mellouli L. A review on worldwide Ephedra history and story: From fossils to natural products mass spectroscopy characterization and biopharmacotherapy potential. Evid. Based Complementary Altern. Med. 2020:1540638.", "ArticleIdList": ["PMC7210547", "32419789"]}, {"Citation": "Abourashed E., El-Alfy A., Khan I., Walker L. Ephedra in Perspective\u2014A Current Review. Phytother. Res. 2003;17:703\u2013712. doi: 10.1002/ptr.1337.", "ArticleIdList": ["10.1002/ptr.1337", "12916063"]}, {"Citation": "Krizevski R., Bar E., Shalit O.R., Levy A., Hagel J.M., Kilpatrick K., Marsolais F., Facchini P.J., Ben-Shabat S., Sitrit Y., et al. Benzaldehyde is a precursor of phenylpropylamino alkaloids as revealed by targeted metabolic profiling and comparative biochemical analyses in Ephedra spp. Phytochemistry. 2012;81:71\u201379. doi: 10.1016/j.phytochem.2012.05.018.", "ArticleIdList": ["10.1016/j.phytochem.2012.05.018", "22727117"]}, {"Citation": "Mendelovich M., Shoshan M., Fridlender M., Mazuz M., Namder D., Nallathambi R., Selvaraj G., Kumari P., Ion A., Wininger S., et al. Effect of Ephedra foeminea active compounds on cell viability and actin structures in cancer cell lines. J. Med. Plant Res. 2017;11:690\u2013702."}, {"Citation": "Ben-Arye E., Mahajna J., Aly R., Ali-Shtayeh M.S., Bentur Y., Lev E., Deng G., Samuels N. Exploring an herbal \u201cwonder cure\u201d for cancer: A multidisciplinary approach. J. Cancer Res. Clin. Oncol. 2016;142:1499\u20131508. doi: 10.1007/s00432-016-2175-7.", "ArticleIdList": ["10.1007/s00432-016-2175-7", "PMC5513733", "27155666"]}, {"Citation": "Ballero M, Foddis C, Sanna C, et al. Pharmacological activities on Ephedra nebrodensis Tineo. Nat Product Res. 2010;24:1115\u20131124.", "ArticleIdList": ["20582807"]}, {"Citation": "Bala A., Kar B., Haldar P.K., Mazumder U.K., Bera S. Evaluation of anticancer activity of Cleome gynandra on Ehrlich\u2019s ascites carcinoma treated mice. J. Ethnopharmacol. 2010;129:131\u2013134. doi: 10.1016/j.jep.2010.03.010.", "ArticleIdList": ["10.1016/j.jep.2010.03.010", "20307641"]}, {"Citation": "Hussein M.A., Boshra S.A. Antitumor and structure antioxidant activity relationship of colchicine on Ehrlich ascites carcinoma (EAC) in female mice. Int. J. Drug Deliv. 2013;5:430\u2013437."}, {"Citation": "Fang C., Cao Y., Liu X., Zeng X.T., Li Y. Serum CA-125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes. Oncotarget. 2017;8:63963\u201363970. doi: 10.18632/oncotarget.19246.", "ArticleIdList": ["10.18632/oncotarget.19246", "PMC5609976", "28969044"]}, {"Citation": "Wang W., Xu X., Tian B., Wang Y., Du L., Sun T., Shi Y., Zhao X., Jing J. The diagnostic value of serum tumor markers CEA, CA19-9, CA-125, CA15-3, and TPS in metastatic breast cancer. Clin. Chim. Acta. 2017;470:51\u201355. doi: 10.1016/j.cca.2017.04.023.", "ArticleIdList": ["10.1016/j.cca.2017.04.023", "28457854"]}, {"Citation": "Biswas N.N., Acharzo A.K., Anamika S., Khushi S., Bokshi B. Screening of natural bioactive metabolites and investigation of antioxidant, antimicrobial, antihyperglycemic, neuropharmacological, and cytotoxicity potentials of Litsea polyantha Juss. ethanolic root extract. Evid. Based Complement. Altern. Med. 2017:3701349.", "ArticleIdList": ["PMC5682899", "29234384"]}, {"Citation": "Cabral C., Efferth T., Pires I.M., Severino P., Lemos M.F. Natural products as a source for new leads in cancer research and treatment. Evid. Based Complement. Altern. Med. 2018:8243680. doi: 10.1155/2018/8243680.", "ArticleIdList": ["10.1155/2018/8243680", "PMC6076959", "30105070"]}, {"Citation": "Alvarez-Rivera G., Ballesteros-Vivas D., Parada-Alfonso F., Iba\u00f1ez E., Cifuentes A. Recent applications of high-resolution mass spectrometry for the characterization of plant natural products. Trends Anal. Chem. 2019;112:87\u2013101. doi: 10.1016/j.trac.2019.01.002.", "ArticleIdList": ["10.1016/j.trac.2019.01.002"]}, {"Citation": "Aydo\u011fan C. Recent advances and applications in LC-HRMS for food and plant natural products: A critical review. Anal. Bioanal. Chem. 2020;412:1973\u20131991. doi: 10.1007/s00216-019-02328-6.", "ArticleIdList": ["10.1007/s00216-019-02328-6", "31912180"]}, {"Citation": "Smith T.A. Phenethylamine and related compounds in plants. Phytochemistry. 1977;16:9\u201318. doi: 10.1016/0031-9422(77)83004-5.", "ArticleIdList": ["10.1016/0031-9422(77)83004-5"]}, {"Citation": "Schaneberg B.T., Crockett S., Bedir E., Khan I.A. The role of chemical fingerprinting: Application to Ephedra. Phytochemistry. 2003;62:911\u2013918. doi: 10.1016/S0031-9422(02)00716-1.", "ArticleIdList": ["10.1016/S0031-9422(02)00716-1", "12590118"]}, {"Citation": "Breitmaier E., Voelter W. Carbon-13 NMR Spectroscopy. 3rd ed. VCH; Weinheim, Germany: 1987."}, {"Citation": "Tamada M., Endo K., Hikino H., Kabuto C. Structure of ephedradine A, a hypotensive principle of Ephedra roots. Tetrahedron Lett. 1979;20:873\u2013876. doi: 10.1016/S0040-4039(01)93575-0.", "ArticleIdList": ["10.1016/S0040-4039(01)93575-0"]}, {"Citation": "Abdel Kader M.S., Kassem F.F., Abdallah R. Two Alkaloids from Ephedra aphylla growing in Egypt. Nat. Prod. Sci. 2003;9:52\u201355."}, {"Citation": "Lv M., Chen J., Gao Y. Metabolomics based on liquid chromatography with mass spectrometry reveals the chemical difference in the stems and roots derived from Ephedra sinica. J. Sep. Sci. 2015;38:3331\u20133336. doi: 10.1002/jssc.201500529.", "ArticleIdList": ["10.1002/jssc.201500529", "26224607"]}, {"Citation": "Kilpatrick K., Pajak A., Hagel J.M., Sumarah W., Lewinsohn E., Facchini J., Marsolais F. Characterization of aromatic aminotransferases from Ephedra sinica Stapf. Amino Acids. 2016;48:1209\u20131220. doi: 10.1007/s00726-015-2156-1.", "ArticleIdList": ["10.1007/s00726-015-2156-1", "26832171"]}, {"Citation": "Starratt A.N., Caveney S. Quinoline-2-carboxylic acids from Ephedra species. Phytochemistry. 1996;42:1477\u20131478. doi: 10.1016/0031-9422(96)00126-4.", "ArticleIdList": ["10.1016/0031-9422(96)00126-4"]}, {"Citation": "Orejola J., Matsuo Y., Saito Y., Tanaka T. Characterization of proanthocyanidin oligomers of Ephedra sinica. Molecules. 2017;22:1308. doi: 10.3390/molecules22081308.", "ArticleIdList": ["10.3390/molecules22081308", "PMC6152249", "28783085"]}, {"Citation": "Zang X., Shang M., Xu F., Liang J., Wang X., Mikage M., Cai S. A-type proanthocyanidins from the stems of Ephedra sinica (Ephedraceae) and their antimicrobial activities. Molecules. 2013;18:5172\u20135189. doi: 10.3390/molecules18055172.", "ArticleIdList": ["10.3390/molecules18055172", "PMC6269821", "23648595"]}, {"Citation": "Miao S.-M., Zhang Q., Bi X.-B., Cui J.-L., Wang M.-L. A review of the phytochemistry and pharmacological activities of Ephedra herb. Chin. J. Nat. Med. 2020;18:321\u2013344. doi: 10.1016/S1875-5364(20)30040-6.", "ArticleIdList": ["10.1016/S1875-5364(20)30040-6", "32451091"]}, {"Citation": "Tao H.M., Wang L.S., Cui Z.C. Dimeric proanthocyanidins from the roots of Ephedra sinica. Planta Med. 2008;74:1823\u20131825. doi: 10.1055/s-0028-1088321.", "ArticleIdList": ["10.1055/s-0028-1088321", "18975262"]}, {"Citation": "Kim I.S., Park Y.J., Yoon S.J., Lee H.B. Ephedrannin A and B from roots of Ephedra sinica inhibit lipopolysaccharide-induced inflammatory mediators by suppressing nuclear factor-\u03baB activation in RAW 264.7 macrophages. Int. Immunopharmacol. 2010;10:1616\u20131625. doi: 10.1016/j.intimp.2010.09.019.", "ArticleIdList": ["10.1016/j.intimp.2010.09.019", "20939997"]}, {"Citation": "Wang Z., Cui Y., Ding G., Zhou M., Ma X., Hou Y., Jiang M., Liu D., Bai G. Mahuannin B An adenylate cyclase inhibitor attenuates hyperhidrosis via suppressing \u03b22-adrenoceptor/cAMP signaling pathway. Phytomedicine. 2017;30:18\u201327. doi: 10.1016/j.phymed.2017.03.002.", "ArticleIdList": ["10.1016/j.phymed.2017.03.002", "28545666"]}, {"Citation": "Kim I.S., Yoon S.J., Park Y.J., Lee H.B. Inhibitory effect of ephedrannins A and B from roots of Ephedra sinica Stapf on melanogenesis. Biochim. Biophys. Acta. 2015;1850:1389\u20131396. doi: 10.1016/j.bbagen.2015.04.001.", "ArticleIdList": ["10.1016/j.bbagen.2015.04.001", "25857772"]}, {"Citation": "Cottiglia F., Bonsignore L., Casu L. Phenolic constituents from Ephedra nebrodensis. Nat. Prod. Res. 2005;19:117\u2013123. doi: 10.1080/14786410410001704714.", "ArticleIdList": ["10.1080/14786410410001704714", "15715254"]}, {"Citation": "Wang Y.Y. Study on chemical constituents of Ephedrae herba. Anti-Infect. Pharm. 2014;11:416\u2013418."}, {"Citation": "Sheriha G.M., Abouamer K., Elshtaiwi B.Z., Ashour A.S., Abed F.A., Alhallaq H.H. Quinoline alkaloids and cytotoxic lignans from Haplophyllum tuberculatum. Phytochemistry. 1987;26:3339\u20133341. doi: 10.1016/S0031-9422(00)82500-5.", "ArticleIdList": ["10.1016/S0031-9422(00)82500-5"]}, {"Citation": "Jain S., Chandra V., Jain P.K., Pathak K., Pathak D., Vaidya A. Comprehensive review on current developments of quinoline-based anticancer agents. Arab. J. Chem. 2019;12:4920\u20134946. doi: 10.1016/j.arabjc.2016.10.009.", "ArticleIdList": ["10.1016/j.arabjc.2016.10.009"]}, {"Citation": "Walczak K., Wnorowski A., Turski W.A., Plech T. Kynurenic acid and cancer: Facts and controversies. Cell. Mol. Life Sci. 2020;77:1531\u20131550. doi: 10.1007/s00018-019-03332-w.", "ArticleIdList": ["10.1007/s00018-019-03332-w", "PMC7162828", "31659416"]}, {"Citation": "Walczak K., Deneka-Hannemann S., Jarosz B., Zgrajka W., Stoma F., Trojanowski T., Turski W.A., Rzeski W. Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells. Pharmacol. Rep. 2014;66:130\u2013136. doi: 10.1016/j.pharep.2013.06.007.", "ArticleIdList": ["10.1016/j.pharep.2013.06.007", "24905318"]}, {"Citation": "Walczak K., Dabrowski W., Langner E., Zgrajka W., Pilat J., Kocki T., Rzeski W., Turski W.A. Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand. J. Gastroenterol. 2011;46:903\u2013912. doi: 10.3109/00365521.2011.579159.", "ArticleIdList": ["10.3109/00365521.2011.579159", "21615226"]}, {"Citation": "Walczak K., Zurawska M., Kis J., Starownik R., Zgrajka W., Bar K., Turski W.A., Rzeski W. Kynurenic acid in human renal cell carcinoma: Its antiproliferative and antimigrative action on Caki-2 cells. Amino Acids. 2012;43:1663\u20131670. doi: 10.1007/s00726-012-1247-5.", "ArticleIdList": ["10.1007/s00726-012-1247-5", "22349835"]}, {"Citation": "Golub A.G., Yakovenko O.Y., Bdzhola V.G., Sapelkin V.M., Zien P., Yarmoluk S.M. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2. J. Med. Chem. 2006;49:6443\u20136450. doi: 10.1021/jm050048t.", "ArticleIdList": ["10.1021/jm050048t", "17064064"]}, {"Citation": "Siddiqui-Jain A., Drygin D., Streiner N., Chua P., Pierre F., O\u2019Brien S.E., Bliesath J., Omori M., Huser N., Ho C., et al. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer Res. 2010;70:10288\u201310298. doi: 10.1158/0008-5472.CAN-10-1893.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-1893", "21159648"]}, {"Citation": "Mettey Y., Vierfond J.-M., Baudry M., Cochet C., Sarrouilhe D. Benzo[c]quinoliziniums: A new family of inhibitors for protein kinase CK II. Bioorganic Med. Chem. Lett. 1997;7:961\u2013964. doi: 10.1016/S0960-894X(97)00127-3.", "ArticleIdList": ["10.1016/S0960-894X(97)00127-3"]}, {"Citation": "Oramas-Royo S., Haidar S., Amesty A., Martin-Acosta P., Feresin G., Tapia A., Aichele D., Jose J., Estevez-Braun A. Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors. Bioorganic Chem. 2020;95:103520. doi: 10.1016/j.bioorg.2019.103520.", "ArticleIdList": ["10.1016/j.bioorg.2019.103520", "31887475"]}, {"Citation": "Kim J.M., Noh E.M., Song H.K., You Y.O., Jung S.H., Kim J.S., Kwon K.B., Lee Y.R., Youn H.J. Silencing of casein kinase 2 inhibits pkc-induced cell invasion by targeting MMP-9 in MCF-7 cells. Mol. Med. Rep. 2018;17:8397\u20138402. doi: 10.3892/mmr.2018.8885.", "ArticleIdList": ["10.3892/mmr.2018.8885", "29658601"]}, {"Citation": "Battistutta R., Cozza G., Pierre F., Papinutto E., Lolli G., Sarno S., O\u2019Brien S.E., Siddiqui-Jain A., Haddach M., Anderes K., et al. Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer. Biochemistry. 2011;50:8478\u20138488. doi: 10.1021/bi2008382.", "ArticleIdList": ["10.1021/bi2008382", "21870818"]}, {"Citation": "Daina A., Zoete V. A BOILED-Egg To Predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11:1117\u20131121. doi: 10.1002/cmdc.201600182.", "ArticleIdList": ["10.1002/cmdc.201600182", "PMC5089604", "27218427"]}, {"Citation": "Campos M.C.O., Castro-Pinto D.B., Ribeiro G.A., Berredo-Pinho M.M., Gomes L.H.F., da Silva Bellieny M.S., Goulart C.M., Echevarria \u00c1., Leon L.L. P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance. Parasitol. Res. 2013;112:2341\u20132351. doi: 10.1007/s00436-013-3398-z.", "ArticleIdList": ["10.1007/s00436-013-3398-z", "PMC3663987", "23572046"]}, {"Citation": "Lynch T., Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am. Fam. Physician. 2007;76:391\u2013396.", "ArticleIdList": ["17708140"]}, {"Citation": "Ghose A.K., Viswanadhan V.N., Wendoloski J.J. A Knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. Qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1999;1:55\u201368. doi: 10.1021/cc9800071.", "ArticleIdList": ["10.1021/cc9800071", "10746014"]}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002;45:2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "Egan W.J., Merz K.M.J., Baldwin J.J. Prediction of drug absorption using multivariate statistics. J. Med. Chem. 2000;43:3867\u20133877. doi: 10.1021/jm000292e.", "ArticleIdList": ["10.1021/jm000292e", "11052792"]}, {"Citation": "Muegge I., Heald S.L., Brittelli D. Simple selection criteria for drug-like chemical matter. J. Med. Chem. 2001;44:1841\u20131846. doi: 10.1021/jm015507e.", "ArticleIdList": ["10.1021/jm015507e", "11384230"]}, {"Citation": "Mosmann T. Rapid colorimetric assays for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55\u201363. doi: 10.1016/0022-1759(83)90303-4.", "ArticleIdList": ["10.1016/0022-1759(83)90303-4", "6606682"]}, {"Citation": "Badr M.O., Edrees N.M., Abdallah A.A., El-Deen N.A., Neamat-Allah A.N., Ismail H.T. Anti-tumor effects of Egyptian propolis on Ehrlich ascites carcinoma. Vet. Ital. 2011;47:341\u2013350.", "ArticleIdList": ["21947972"]}, {"Citation": "Chemical Computing Group; Montreal, QC, Canada: 2016. Molecular Operating Environment (MOE), Version 2016.08."}]}], "History": [{"Year": "2023", "Month": "11", "Day": "21"}, {"Year": "2023", "Month": "12", "Day": "17"}, {"Year": "2023", "Month": "12", "Day": "21"}, {"Year": "2024", "Month": "1", "Day": "12", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "11", "Hour": "7", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "11", "Hour": "1", "Minute": "13"}, {"Year": "2023", "Month": "12", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["38202783", "PMC10780881", "10.3390/molecules29010199", "molecules29010199"]}}]}